News|Articles|February 26, 2026

Hospital Pharmacy and Supply Chain Leaders Want to Be Heard: Are you Ready to Listen?

Author(s) Tecsys

Valerie Bandy and Ryan Rotar, both from Tecsys, examine how hospital pharmacy leaders are reshaping their expectations and prioritizing value-driven partnerships over traditional transactional vendor relationships. They explore the growing shift toward self-distribution and direct purchasing, as well as how transparency and proactive communication are now essential to mitigating logistics risk and safeguarding patient care. This interview stresses technology’s role as a critical enabler of data visibility, empowering manufacturers to build long-term trust through consistent performance and shared accountability. Read this Q&A to learn more about:

  • How hospital pharmacies evaluate manufacturers and what separates true partners from transactional vendors.
  • Where direct purchasing changes expectations around risk, communication, logistics, and technology.
  • Practical ways manufacturers can build trust, improve collaboration, and create long-term financial value with health systems.

DOWNLOAD Q&A


Related to this article

Pharmaceutical Executive Daily
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.